Bibliome.ai browser hg19
Search
About
Stats
FAQ
PIK3CA c.1457T>C ;(p.F486S)
Variant ID: 3-178928271-T-C
NM_006218.2(
PIK3CA
):c.1457T>C;(p.F486S)
This variant was identified in 3 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
Systematic review and meta-analysis of genomic alterations in acral melanoma.
Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05
Variant appearance in text: PI3K: F486S
PubMed Link:
35229492
Variant Present in the following documents:
PCMR-35-369-s003.xlsx, sheet 12
View BVdb publication page
PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Ilic, Nina N; Utermark, Tamara T; Widlund, Hans R HR; Roberts, Thomas M TM
Publication Date: 2011-09-13
Variant appearance in text: PIK3CA: F486S
PubMed Link:
21876152
Variant Present in the following documents:
Main text
View BVdb publication page
Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).
Therapeutics And Clinical Risk Management
Henkes, Martin M; van der Kuip, Heiko H; Aulitzky, Walter E WE
Publication Date: 2008-02
Variant appearance in text: PI3K: Phe486Ser
PubMed Link:
18728706
Variant Present in the following documents:
Main text
tcrm-0401-163.pdf
View BVdb publication page